KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NexPoint Residential Trust (NXRT) Asset Writedowns and Impairment (2020 - 2025)

NexPoint Residential Trust (NXRT) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $466000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 25.68% to $466000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 57.66% decrease, with the full-year FY2025 number at $1.6 million, down 57.66% from a year prior.
  • Asset Writedowns and Impairment was $466000.0 for Q4 2025 at NexPoint Residential Trust, up from $443000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.5 million in Q3 2023 to a low of $183000.0 in Q2 2025.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2024 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 147.66% in 2022, then tumbled 83.85% in 2025.
  • NexPoint Residential Trust's Asset Writedowns and Impairment stood at $963000.0 in 2021, then skyrocketed by 147.66% to $2.4 million in 2022, then tumbled by 41.55% to $1.4 million in 2023, then crashed by 55.02% to $627000.0 in 2024, then decreased by 25.68% to $466000.0 in 2025.
  • Per Business Quant, the three most recent readings for NXRT's Asset Writedowns and Impairment are $466000.0 (Q4 2025), $443000.0 (Q3 2025), and $183000.0 (Q2 2025).